Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Day One Biopharmaceuticals (DAWN) Operating Margin (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Operating Margin for 2 consecutive years, with 51.12% as the latest value for Q4 2025.

  • For Q4 2025, Operating Margin rose 17256.0% year-over-year to 51.12%; the TTM value through Dec 2025 reached 80.76%, up 8489.0%, while the annual FY2025 figure was 80.76%, 8489.0% up from the prior year.
  • Operating Margin was 51.12% for Q4 2025 at Day One Biopharmaceuticals, up from 60.94% in the prior quarter.
  • The five-year high for Operating Margin was 31.61% in Q3 2024, with the low at 1401.45% in Q2 2024.